VASUDHA PHARMA CHEM LTD

Overview

VASUDHA PHARMA CHEM LTD is an active pharmaceutical ingredient (API) supplier with 36 active FDA Type II Drug Master Files, covering AMITRIPTYLINE HYDROCHLORIDE USP; ARIPIPRAZOLE USP; CISAPRIDE MONOHYDRATE USP; CLOPIDOGREL BISULFATE USP; CYCLOBENZAPRINE HCL USP; CYPROHEPTADINE HCL USP.

API / Drug Master Files

VASUDHA PHARMA CHEM LTD holds 36 active (38 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ARIPIPRAZOLE USPActive2026-03-10
• TRAZODONE HYDROCHLORIDE USPActive2026-02-12
• DILTIAZEM HYDROCHLORIDE USPActive2024-10-26
• TELMISARTAN USPActive2023-09-08
• PANTOPRAZOLE SODIUM USP (PROCESS-II)Active2023-06-23
• RUPATADINE FUMARATEActive2023-05-31
• RIVAROXABANActive2023-03-31
• LEVETIRACETAM USPActive2023-03-09
• OLMESARTAN MEDOXOMIL USPActive2023-02-22
• TAMSULOSIN HYDROCHLORIDE USPActive2022-09-30
• MIRABEGRON IHActive2022-04-01
• DIMETHYL FUMARATE IHActive2021-04-01
• ITRACONAZOLE USPActive2020-10-09
• LORATADINE USP (PROCESS-II)Active2020-05-15
• CLOPIDOGREL BISULFATE USPActive2019-05-27

Showing 15 of 38 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to VASUDHA PHARMA CHEM LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.